BPMambaMIL: A bio-inspired prototype-guided multiple instance learning for oncotype DX risk assessment in histopathology

•BPMambaMIL, a novel prototype-guided model, enhances breast cancer recurrence prediction from pathology images.•Bio-inspired prototype selection effectively captures complex histopathological features.•BPMambaMIL outperforms state-of-the-art models, especially in classifying high-risk Oncotype DX s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Computer methods and programs in biomedicine Ročník 272; s. 109039
Hlavní autoři: Guo, Yongxin, Su, Ziyu, Koyun, Onur C., Lu, Hao, Wesolowski, Robert, Tozbikian, Gary, Niazi, M. Khalid Khan, Gurcan, Metin N.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Ireland Elsevier B.V 01.12.2025
Témata:
Algorithms
Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Computational pathology
Deep learning
Female
Humans
Mamba
Multiple-Instance Learning Algorithms
Oncotype-DX
Prognosis
Risk Assessment
Deep learning
Mamba
Breast cancer
Oncotype-DX
Computational pathology
ISSN:0169-2607, 1872-7565, 1872-7565
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:•BPMambaMIL, a novel prototype-guided model, enhances breast cancer recurrence prediction from pathology images.•Bio-inspired prototype selection effectively captures complex histopathological features.•BPMambaMIL outperforms state-of-the-art models, especially in classifying high-risk Oncotype DX scores (accuracy: 0.714 vs 0.419 for baseline models) in a clinical dataset.•Cross-dataset evaluations on two external datasets demonstrate robust generalizability of BPMambaMIL across clinical scenarios. Breast cancer remains one of the most prevalent malignancies among women, with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) breast cancers constituting a majority, with treatment decisions often guided by genomic assays such as the 21-gene recurrence score assay, Oncotype DX. Although Oncotype DX provides critical prognostic and predictive insights, its high cost and limited accessibility create substantial barriers, especially for patients with constrained financial resources. To reduce the test cost, we aim to leverage H&E-stained whole slide images (WSIs) to predict Oncotype DX risk. Since WSIs are extremely large and contain redundant information, directly processing them is both computationally expensive and prone to errors. To address these limitations, we introduce a bio-inspired prototype-guided model (BPMambaMIL), a novel weakly supervised learning framework that integrates the Mamba mechanism with prototypical guidance to predict Oncotype DX score intervals directly from pathology images. Our model was evaluated on an in-house dataset with clinical Oncotype DX scores, where it achieved an AUC of 0.839, a 5.61 % improvement over the baseline model (MambaMIL), and demonstrated robust predictive performance, particularly in identifying high-risk score ranges (accuracy: 0.714 vs 0.419). Further assessments on two public breast cancer pathology image datasets using six state-of-the-art models underscored BPMambaMIL’s generalizability on research-based ODX scores and binary tumor classification tasks. By evaluating various clinical scenarios, the proposed method not only enhances the accuracy of breast cancer recurrence risk predictions but also offers a cost-effective alternative to genomic assays, thus improving clinical outcomes.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0169-2607
1872-7565
1872-7565
DOI:10.1016/j.cmpb.2025.109039